Literature DB >> 1756027

Effect of antioxidants on oxidative modification of LDL.

H Esterbauer1, H Puhl, M Dieber-Rotheneder, G Waeg, H Rabl.   

Abstract

Human low density lipoprotein (LDL) with a molecular mass of 2.5 million contains on average 1300 molecules of polyunsaturated fatty acids (PUFAs) bound in the different lipid classes. The predominant antioxidant in LDL is alpha-tocopherol, with an average of 6 molecules in each LDL particle. The other substances with potential antioxidant activity are: gamma-tocopherol, beta-carotene, alpha-carotene, lycopene, cryptoxanthin, cantaxanthin, phytofluene and ubiquinol-10. Each is present in amounts of only 1/20th to 1/300th of that of alpha-tocopherol. If LDL is exposed to oxidative conditions (Cu++ ions, macrophages) a lag phase precedes the oxidation of PUFAs. During the lag phase the antioxidants disappear with alpha-tocopherol the first to go and beta-carotene the last. The lag phase, which can readily be determined, is an index of the oxidation resistance of LDL. If LDL is loaded with vitamin E in vitro its oxidation resistance increases linearly with its alpha-tocopherol content according to the equation, y = kx+a. The same relationship is applicable if the alpha-tocopherol content of LDL is increased by taking oral vitamin E. Daily doses of 150, 225, 800 and 1200 IU RRR-alpha-tocopherol increased the LDL alpha-tocopherol on average to 138%, 158%, 144% and 215% of the initial value, the oxidation resistance being increased to 118%, 156%, 135% and 175%, respectively. The efficiency of vitamin E-dependent (= k) and the vitamin independent (= a) oxidation resistance seem to be subject specific with strong individual variation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1756027     DOI: 10.3109/07853899109150520

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  27 in total

Review 1.  The Gordon Wilson Lecture. Plasma cholesterol: atherogenesis and mortality.

Authors:  W R Fisher
Journal:  Trans Am Clin Climatol Assoc       Date:  1993

2.  Time-course studies by synchrotron X-ray solution scattering of the structure of human low-density lipoprotein during Cu(2+)-induced oxidation in relation to changes in lipid composition.

Authors:  D F Meyer; A S Nealis; C H Macphee; P H Groot; K E Suckling; K R Bruckdorfer; S J Perkins
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

Review 3.  Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus.

Authors:  Surapon Tangvarasittichai
Journal:  World J Diabetes       Date:  2015-04-15

4.  Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke: Basel Prospective Study.

Authors:  K F Gey; H B Stähelin; M Eichholzer
Journal:  Clin Investig       Date:  1993-01

Review 5.  Modification of atherosclerosis by agents that do not lower cholesterol.

Authors:  J G Cleland; D M Krikler
Journal:  Br Heart J       Date:  1993-01

6.  Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor.

Authors:  G Ambrosio; A Oriente; C Napoli; G Palumbo; P Chiariello; G Marone; M Condorelli; M Chiariello; M Triggiani
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

7.  Effect of n-3 fatty acid-rich fish oil supplementation on the oxidation of low density lipoproteins.

Authors:  E N Frankel; E J Parks; R Xu; B O Schneeman; P A Davis; J B German
Journal:  Lipids       Date:  1994-04       Impact factor: 1.880

Review 8.  Why are low-density lipoproteins atherogenic?

Authors:  S G Young; S Parthasarathy
Journal:  West J Med       Date:  1994-02

9.  A simplified in vitro model of oxidant injury using vascular endothelial cells.

Authors:  L Li; B H Lau
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-07       Impact factor: 2.416

10.  Oxidative modification of triglyceride-rich lipoproteins in hypertriglyceridemic rats following magnesium deficiency.

Authors:  E Gueux; C Cubizolles; L Bussière; A Mazur; Y Rayssiguier
Journal:  Lipids       Date:  1993-06       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.